作者
Francis Y Yao, Robert K Kerlan Jr, Ryutaro Hirose, Timothy J Davern III, Nathan M Bass, Sandy Feng, Marion Peters, Norah Terrault, Chris E Freise, Nancy L Ascher, John P Roberts
发表日期
2008/9
期刊
Hepatology
卷号
48
期号
3
页码范围
819-827
出版商
Wiley Subscription Services, Inc., A Wiley Company
简介
We previously reported encouraging results of down‐staging of hepatocellular carcinoma (HCC) to meet conventional T2 criteria (one lesion 2–5 cm or two to three lesions <3 cm) for orthotopic liver transplantation (OLT) in 30 patients as a test of concept. In this ongoing prospective study, we analyzed longer‐term outcome data on HCC down‐staging in a larger cohort of 61 patients with tumor stage exceeding T2 criteria who were enrolled between June 2002 and January 2007. Eligibility criteria for down‐staging included: (1) one lesion >5 cm and up to 8 cm; (2) two to three lesions with at least one lesion >3 cm and not exceeding 5 cm, with total tumor diameter up to 8 cm; or (3) four to five lesions with none >3 cm, with total tumor diameter up to 8 cm. A minimum observation period of 3 months after down‐staging was required before OLT. Tumor down‐staging was successful in 43 patients (70.5%). Thirty‐five …
引用总数
20082009201020112012201320142015201620172018201920202021202220232024326474643696254483527432326202421